Transaction Date | Recipient | Shares | Type | Price | Value |
---|---|---|---|---|---|
20th November 2020 | David F Burgstahler | 4,936,926 | Other acquisition or disposition | $0.00 | |
20th November 2020 | Sriram Venkataraman | 4,936,926 | Other acquisition or disposition | $0.00 | |
20th November 2020 | Capital Partners Iii Gp, L.P. Avista | 4,936,926 | Other acquisition or disposition | $0.00 | |
1st October 2020 | Brian A Markison | 2,277 | Grant/award etc. | $0.00 | |
10th August 2020 | Brian A Markison | 1,354 | Grant/award etc. | $0.00 | |
21st May 2020 | Fred G Weiss | 17,778 | Payment by withholding | $4.60 | $81,778.80 |
21st May 2020 | Gregory L Cowan | 11,112 | Payment by withholding | $4.60 | $51,115.20 |
20th May 2020 | Brian A Markison | 249,787 | Grant/award etc. | $0.00 | |
20th May 2020 | Fred G Weiss | 38,716 | Grant/award etc. | $0.00 | |
20th May 2020 | Gregory L Cowan | 38,716 | Grant/award etc. | $0.00 |
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 7/10.
Osmotica Pharmaceuticals Plc operates as a biopharmaceutical company. Its products include M-72, Lorzone, ConZip, OB Complete, and Divigel. The company was founded in 1986 and is headquartered in Bridgewater, NJ.